Investigating the potential of Shikonin as a novel hypertrophic scar treatment

BACKGROUND: Hypertrophic scarring is a highly prevalent condition clinically and results from a decreased number of apoptotic fibroblasts and over-abundant production of collagen during scar formation following wound healing. Our previous studies indicated that Shikonin, an active component extracte...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Chen, Xie, Yan, Dong, Ying, Su, Yonghua, Upton, Zee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537585/
https://www.ncbi.nlm.nih.gov/pubmed/26275605
http://dx.doi.org/10.1186/s12929-015-0172-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537585/
https://www.ncbi.nlm.nih.gov/pubmed/26275605
http://dx.doi.org/10.1186/s12929-015-0172-9

Ejemplares similares